The second episode of THE+TRIBUTE features Auckland father Brent, who describes developing pericarditis following his first dose of the Covid-19 vaccine in 2021, and the subsequent impact on his family, health and trust in public institutions.
Initially trusting of the medical system and pharmaceutical companies, he says he became increasingly uneasy with what he perceived as a fear-based narrative and limited public discussion of potential risks. Following two wider family members’ cancer diagnoses, Brent says unspoken expectations within his family intensified. On 5 September 2021 he received his first Pfizer dose. Within five days, he experienced severe pain:
“I started getting a big knot in my back, which travelled up, to the point where I was in extreme pain. And then it came into my chest.”
He drove himself to hospital in the early hours, telling staff the vaccine was the only recent change in his life. Although he says his concerns were initially dismissed, tests later confirmed pericarditis – inflammation of the sac surrounding the heart. Brent, who has previously suffered multiple broken bones and gout attacks, describes the pain as “so incredibly painful” and worse than any injury he had experienced.
After 24 hours of monitoring, Brent says he was discharged with advice to proceed with his second dose because “COVID is way worse”. He recalls feeling stunned by that recommendation:
“I was in absolute disbelief… If that’s the calibre of our doctors, like, seriously, we’re in big, big trouble.”
Brent was initially granted a temporary medical exemption from Covid-19 vaccination mandates and the then–Covid-19 Protection Framework settings, which had restricted access to many services and venues for the unvaccinated. However, he says a subsequent exemption application was declined and he was advised he should still receive a second dose.

Official data from Health New Zealand show that very few New Zealanders who reported serious adverse reactions were granted medical exemptions to mandated vaccination. Of those who applied on the basis of myocarditis or pericarditis after a first dose (119), only 43 received exemptions. Similar patterns applied to applications based on severe anaphylaxis, other significant adverse reactions, and pre-existing inflammatory cardiac conditions.

Brent’s family was further affected when his 15‑year‑old son developed similar symptoms several weeks later.
“One night, my son was sitting doing his homework. He goes, ‘I’ve got this real sore back.’”
His son was admitted to hospital and then left largely bedridden for three to four months, with even walking to the letterbox leaving him exhausted. He missed substantial schooling, particularly in maths and physics, making his ambition of becoming an engineer significantly harder to pursue.
Another son was excluded from his football team because of his unvaccinated status.
With limited support offered through conventional channels, Brent says the family turned to a range of alternative therapies at considerable personal cost:
“We spent a lot of money doing a lot of the more alternative treatments. It was a tough two years, it definitely left us quite financially stretched. Now I seem to be okay. But there are still a whole heap of unknowns.”
Brent says he has lost friends whom he believes died as a result of vaccination, and he keeps his vaccine card as a stark reminder. The overall experience, he says, has deeply shaken his trust in pharmaceutical companies, Medsafe, and political and medical leadership, particularly around what he describes as inadequate informed consent about risks such as myocarditis and pericarditis.

“There was grief around realising that I couldn’t trust people that I thought I could. Yeah, real grief and anger, and fear actually. The whole thing has made me incredibly cynical, untrusting and angry.”
He also describes how his faith has been central in coming to terms with what has happened and in his decision to decline government compensation:
“I’m a man of faith as well, so that really helped massively.”
Watch Brent’s full 20-minute episode now on YouTube or Spotify



